Received July 04, 2008; Accepted September 11, 2008.
Abstract
Objectives
The purpose of this study was to evaluate the relationship of nonalcoholic fatty liver and cardiovascular risk factors.
Methods
This study was conducted to investigate the association of nonalcoholic fatty liver and cardiovascular risk factors for adult men (n=2976) and women (n=2442) who were over 19 years old, after excluding the HBsAg(+) or anti-HCV(+) patients and the men and women with increased alcohol intake (men: 40 g/week, women: 20 g/week).
Results
Compared with the normal liver subjects, the nonalcoholic fatty liver subjects showed a significantly increased frequency of abnormal systolic blood pressure (≥120 mmHg), fasting blood sugar (≥100 mg/dL), total cholesterol (≥200 mg/dL), triglyceride (≥150 mg/dL), high density lipoprotein cholesterol (<40 mg/dL), low density lipoprotein cholesterol (≥130g m/dL) and abdominal obesity in men, and all these measures were significantly increased in the women except for abnormal HDL cholesterol. After adjusting for the body mass index, age, smoking, exercise and a nonalcoholic liver, the odds ratios of an abnormal waist hip ratio were 1.35(95% Confidence Interval=1.05-4.72) in the mild fatty liver, 1.61(1.19-2.18) in the moderate fatty liver, 2.77(1.57-4.92) in the severe fatty liver compared with a normal liver. The adjusted odds ratios for abnormal fasting blood sugar were 1.26(1.03-1.53) in the mild fatty liver, 1.62(1.27-2.06) in the moderate fatty lliver and 1.77(1.12-2.78) in the severe fatty liver. The adjusted odds ratios for abnormal triglyceride were 1.38(1.11-1.72) in the mild fatty liver, 1.73(0.33-2.24) in the moderate fatty liver and 1.91(1.17-3.10) in the severe fatty liver of men. Adjusted odds ratios for abnormal triglyceride were 1.50(1.04-2.15) in mild, 1.71(1.07-2.68) in moderate, 1.81(0.69-4.38) in severe fatty liver of women.
Conclusions
The nonalcoholic fatty liver subjects had more cardiovascular risk factors compared with the normal liver subjects. Thus, prevention and treatment of the nonalcoholic fatty liver is necessary by lifestyle modifications such as restriction of alcohol intake, no smoking, exercise and adequate eating habits.
Sheth SG,Gordon FD,Chopra S. Nonalcoholic steatohepatitis. Ann Intern Med 1997;126(2):137–145.
2.
Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346(16):1221–1231.
3.
Poonawala A,Nair SP,Thuluvath PJ. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: A case-control study. Hepatology 2000;32(4 Pt 1):689–692.
4.
Matteoni CA,Younossi ZM,Gramlich T,Boparai N,Liu YC,McCullough AJ. Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity. Gastroenterology 1999;116(6):1413–1419.
5.
Knobler H,Schattner A,Zhornicki T,Malnick SD,Keter D,Sokolovskaya N,et al. Fatty liver: An additional and treatable feature of the insulin resistance syndrome. QJM 1999;92(2):73–79.
6.
McCullough AJ. Update on nonalcoholic fatty liver disease. J Clin Gastroenterol 2002;34(3):255–262.
7.
McCullough AJ. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. Clin Liver Dis 2004;8(3):521–533.
Yeon JE. Nonalcoholic fatty liver disease: Pathogenesis and treatment. Korean J Med 2006;70(3):246–252. (Korean)
11.
Kim HJ,Kim DJ,Kim SK,Kim SH,Rhee YM,Ahn CW,et al. Metabolic abnormalities according to severity of non-alcoholic fatty liver disease in Korean adults. J Korean Soc Endocrinol 2002;17(4):514–525. (Korean)
12.
Jin SY. Fatty liver. Korean J Hepatol 2006;12(1):112–115. (Korean)
13.
Marchesini G,Brizi M,Bianchi G,Tomassetti S,Bugianesi E,Lenzi M,et al. Nonalcoholic fatty liver disease: A feature of the metabolic syndrome. Diabetes 2001;50(8):1844–1850.
14.
Marchesini G,Brizi M,Morselli-Labate AM,Bianchi G,Bugianesi E,McCullough AJ,et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 1999;107(5):450–455.
15.
Musso G,Gambino R,De Michieli F,Cassader M,Rizzetto M,Durazzo M,et al. Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis. Hepatology 2003;37(4):909–916.
16.
Kim SM,Kim JA,Han JH,Cho KH,Yoon D. Nonalcoholic fatty liver disease and metabolic syndrome in nonobese, nondiabetic adults. Korean J Obes 2006;15(1):44–51. (Korean)
17.
Kim KS. The relationship between fatty liver and parameters of metabolic syndrome in the non alcoholic health screen examinees. Kosin Med J 2006;21(1):207–217. (Korean)
18.
Seo SH,Lee HW,Park HW,Jang BG,Chung WJ,Park KS,et al. Prevalence and associated factors of nonalcoholic fatty liver disease in the health screen examinees. Korean J Med 2006;70(1):26–32. (Korean)
19.
Nah EH,Park JY. Metabolic characteristics and associated factors of nonalcoholic fatty liver disease diagnosed at medical checkups. Korean J Lab Med 2008;28(3):244–250. (Korean)
20.
Park SK,Lee HJ,Lee DH,Lee SK,Chun BY,Kim SA,et al. Associations of non alcoholic fatty liver with the metabolic syndrome and serum carotenoids. J Prev Med Public Health 2008;41(1):39–44. (Korean)
21.
Chobanian AV,Bakris GL,Black HR,Cushman WC,Green LA,Izzo JL Jr,et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42(6):1206–1252.
22.
Genuth S,Alberti KG,Bennett P,Buse J,Defronzo R,Kahn R,et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003;26(11):3160–3167.
23.
Einhorn D,Reaven GM,Cobin RH,Ford E,Ganda OP,Handelsman Y,et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract 2003;9(3):237–252.
24.
World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Geneva: WHO Department of Noncommunicable Disease Surveillance; 1999.
25.
Seppälä-Lindroos A,Vehkavaara S,Häkkinen AM,Goto T,Westerbacka J,Sovijärvi A,et al. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab 2002;87(7):3023–3028.
26.
Sanyal AJ,Campbell-Sargent C,Mirshahi F,Rizzo WB,Contos MJ,Sterling RK,et al. Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001;120(5):1183–1192.
27.
Anderson AJ,Sobocinski KA,Freedman DS,Barboriak JJ,Rimm AA,Gruchow HW. Body fat distribution, plasma lipids, and lipoproteins. Arteriosclerosis 1988;8(1):88–94.
28.
Akahoshi M,Amasaki Y,Soda M,Tominaga T,Ichimaru S,Nakashima E,et al. Correlation between fatty liver and coronary risk factors: A population study of elderly men and women in Nagasaki, Japan. Hypertens Res 2001;24(4):337–343.
29.
Kang JH,Lee SW,Lee HS,Cho CY,Yu BY. The relation of nonalcoholic fatty liver sisease to metabolic syndrome. J Korean Acad Fam Med 2004;25(10):746–753. (Korean)
30.
Adams LA,Lymp JF,St Sauver J,Sanderson SO,Lindor KD,Feldstein A,et al. The natural history of nonalcoholic fatty liver disease: A population-based cohort study. Gastroenterology 2005;129(1):113–121.
,1
